News | February 23, 2024
AstraZeneca completes acquisition of Gracell
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F
The acquisition will build on AstraZeneca’s expertise in respiratory syncytial virus
The restructuring aims to create synergies across the business and strengthen capital structure
Zydus’s revenue growth was led by India and EU formulations businesses in addition to that in the emerging markets.
Pelabresib recently met its primary endpoint of spleen volume reduction and demonstrated favorable trends in symptom improvement
Agreed Price of US$43 per share to deliver 48% premium to unaffected price on May 25, 2023
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
The company received gross proceeds of approximately US$1.7 million and net proceeds,
H.C. Wainwright & Co. acted as the exclusive placement agent for the offering
According to Sun Pharma, the purpose of the strategic investment is to obtain access to the technology for certain compounds and territories while also fostering the development of novel pharmaceutical delivery systems.
Subscribe To Our Newsletter & Stay Updated
